The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmurfit Kappa Regulatory News (SKG)

Share Price Information for Smurfit Kappa (SKG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,500.00
Bid: 3,490.00
Ask: 3,494.00
Change: 72.00 (2.10%)
Spread: 4.00 (0.115%)
Open: 3,360.00
High: 3,506.00
Low: 3,360.00
Prev. Close: 3,428.00
SKG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Smurfit Kappa Group plc

24 May 2018 15:20

RNS Number : 2283P
BlackRock Group
24 May 2018
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Smurfit Kappa Group plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.001 ordinary shares

Date of dealing

23 May 2018

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

12,751,700 (5.37%)

0 (0.00%)

(2) Derivatives (other than options)

174,623 (0.07%)

0 (0.00%)

(3) Options and agreements to purchase/sell

0 (0.00%)

138,000 (0.05%)

Total

12,926,323 (5.44%)

138,000 (0.05%)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

1,575

EUR 34.5000

Sale

18,467

GBP 30.1152

Sale

583

GBP 30.1507

Sale

2,835

EUR 34.2915

Sale

2,951

EUR 34.4307

Sale

6,792

EUR 34.5000

Please note: there was also a Transfer In of 9,545 Shares

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing Long

14,901

EUR 34.3957

CFD

Increasing Long

587

EUR 34.5442

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Written

58,000

EUR 35.5350

European

12/07/2018

EUR 0.7417

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9) YES

 

Date of disclosure

24 May 2018

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

40,000

EUR 36.1530

European

13/06/2018

Call Option

Written

40,000

EUR 36.2972

European

27/06/2018

Call Option

Written

58,000

EUR 35.5350

European

12/07/2018

 

Notes

 

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2. For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEEADSLAFPPEFF
Date   Source Headline
18th Aug 202311:15 amRNSBlock listing Interim Review
2nd Aug 20237:00 amBUSHalf-Year Report
13th Jul 20237:00 amBUSNotice of Results
11th Jul 20232:01 pmRNSHolding(s) in Company
21st Jun 20235:18 pmRNSHolding(s) in Company
13th Jun 20234:15 pmRNSHolding(s) in Company
28th Apr 20233:36 pmRNSHolding(s) in Company
28th Apr 20232:47 pmRNSResult of AGM
28th Apr 20231:34 pmRNSDirectorate Change
28th Apr 20237:00 amBUSTrading Statement
19th Apr 202312:36 pmRNSHolding(s) in Company
19th Apr 20237:00 amBUSNotice of Results
28th Mar 20233:00 pmRNSPublication of Annual Report and Notice of Meeting
24th Mar 20234:08 pmRNSDirector Declaration
20th Mar 202310:00 amBUSStatement re Russian Operations
28th Feb 20235:10 pmRNSTotal Voting Rights
20th Feb 20239:26 amRNSBlock listing Interim Review
13th Feb 20237:00 amRNSBlock Listing Application
8th Feb 20237:00 amBUSFinal Results
18th Jan 20237:00 amBUSNotice of Results
16th Jan 20234:16 pmRNSHolding(s) in Company
12th Jan 20234:49 pmRNSHolding(s) in Company
4th Jan 20234:42 pmBUSDirectorate change
30th Dec 202212:32 pmRNSTotal Voting Rights
19th Dec 20224:26 pmRNSDirector Declaration
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSTransaction in Own Shares
14th Dec 202210:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:00 amRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20227:00 amBUSStatement re Share Buy-Back Transaction
2nd Dec 20223:57 pmRNSDirectorate Change
30th Nov 20225:28 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amBUSNotice of Results
10th Oct 20225:22 pmRNSAppointment of Senior Independent Director
19th Sep 20227:00 amBUSAcquisition
6th Sep 20224:35 pmRNSHolding(s) in Company
18th Aug 20223:42 pmRNSBlock listing Interim Review
27th Jul 20227:00 amBUSHalf-year Report
7th Jul 20227:00 amBUSNotice of Results
13th Jun 202212:47 pmBUSStatement re Birmingham Paper Mill
1st Jun 20224:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amBUSStatement re investment of over 35 million euro in first Moroccan plant
20th May 20224:38 pmRNSDirector/PDMR Shareholding
20th May 20224:34 pmRNSDirector/PDMR Shareholding
29th Apr 20223:26 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.